≡ Menu

Hospira Injectable Drug Products: Recall – Visible Particulates from Defective Glass Vials

A Drug & Medical Device Recall And/Or Safety Alert Has Been Issued: Hospira Injectable Drug Products: Recall – Visible Particulates from Defective Glass Vials. According to the Food & Drug Administration FDA’s MedWatch:

Symptoms of particulate matter injected into a patient might include bleeding, bruising, inflammation, itching, rash, chest pain and respiratory symptoms.

For more information on the drug or medical device recall or safety alert, read the Food & Drug Administration’s FDA’s drug or medical device recall or safety alert: Hospira Injectable Drug Products: Recall – Visible Particulates from Defective Glass Vials.

To report an adverse reaction, problem or other issue with a drug or medical device, submit a drug or medical device complaint to the government at fda.gov or MedWatch.

If you have thoughts on the drug or medical device recall or safety alert, share your drug or medical device recall or safety alert comments below.

Powered by WPeMatico

{ 0 comments… add one }

Leave a Comment